[go: up one dir, main page]

HK1005872A1 - 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same - Google Patents

2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same

Info

Publication number
HK1005872A1
HK1005872A1 HK98105004A HK98105004A HK1005872A1 HK 1005872 A1 HK1005872 A1 HK 1005872A1 HK 98105004 A HK98105004 A HK 98105004A HK 98105004 A HK98105004 A HK 98105004A HK 1005872 A1 HK1005872 A1 HK 1005872A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
same
hydrogen atom
piperazinyl
processes
Prior art date
Application number
HK98105004A
Other languages
English (en)
Inventor
Naoki Kai
Katsuhiko Hino
Masato Sakamoto
Tatsuya Kon
Makoto Oka
Kiyoshi Furakawa
Yoshiaki Ochi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of HK1005872A1 publication Critical patent/HK1005872A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98105004A 1989-03-03 1998-06-05 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same HK1005872A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5254489 1989-03-03

Publications (1)

Publication Number Publication Date
HK1005872A1 true HK1005872A1 (en) 1999-01-29

Family

ID=12917732

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105004A HK1005872A1 (en) 1989-03-03 1998-06-05 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same

Country Status (15)

Country Link
US (1) US5021421A (xx)
EP (1) EP0385237B1 (xx)
KR (1) KR0149649B1 (xx)
AT (1) ATE107922T1 (xx)
AU (1) AU623981B2 (xx)
CA (1) CA2011346C (xx)
DD (1) DD292909A5 (xx)
DE (1) DE69010232T2 (xx)
DK (1) DK0385237T3 (xx)
ES (1) ES2058630T3 (xx)
FI (1) FI94413C (xx)
HK (1) HK1005872A1 (xx)
HU (1) HU204810B (xx)
NO (1) NO177095C (xx)
RU (1) RU2075478C1 (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041443A (en) * 1989-02-21 1991-08-20 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
KR100307660B1 (ko) * 1993-06-25 2001-12-28 스즈키 츠네시 도파민재소비저해제
CA2144669A1 (en) 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
US6458789B1 (en) * 1999-09-29 2002-10-01 Lion Bioscience Ag 2-aminopyridine derivatives and combinatorial libraries thereof
IL162859A0 (en) * 2002-02-05 2005-11-20 Novo Nordisk As Novel aryl-and heteroarylpiperazines
AU2006228378A1 (en) 2005-03-31 2006-10-05 Pfizer Products Inc. Cyclopentapyridine and tetrahydroquinoline derivatives
JP5121707B2 (ja) 2005-07-04 2013-01-16 ハイ ポイント ファーマシューティカルズ,エルエルシー 新規医薬
CA2653062A1 (en) 2006-05-23 2007-11-29 Transtech Pharma, Inc. 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体
US8354121B2 (en) 2006-06-09 2013-01-15 Dainippon Sumitomo Pharma Co., Ltd. Tape preparation
DK2049529T3 (da) * 2006-07-14 2010-11-29 Merck Sharp & Dohme Substituerede diazepan-orexin-receptor- antagonister
RS55585B1 (sr) 2006-11-22 2017-06-30 Clinical Research Associates LLC Postupci za lečenje daunovog sindroma, krhkog x sindroma i autizma
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
CN101531634B (zh) * 2008-03-10 2013-09-18 北京德众万全医药科技有限公司 一种高纯度的布南色林及其制备方法
CN101530412A (zh) * 2008-03-10 2009-09-16 北京德众万全医药科技有限公司 一种布南色林的药物组合物及其制备方法
CN101747272B (zh) * 2008-12-02 2012-11-28 浙江华海药业股份有限公司 布南色林晶型b及其制备方法
CN101747273B (zh) * 2008-12-02 2012-03-07 浙江华海药业股份有限公司 布南色林中间体的制备方法
CN101766626B (zh) * 2008-12-30 2012-03-07 丽珠医药集团股份有限公司 一种治疗精神分裂症的含布南色林的口服制剂
US20120121515A1 (en) 2009-03-13 2012-05-17 Lenny Dang Methods and compositions for cell-proliferation-related disorders
LT2448582T (lt) 2009-06-29 2017-07-10 Agios Pharmaceuticals, Inc. Chinolin-8-sulfonamido dariniai, turintys priešvėžinį aktyvumą
CN101619039B (zh) * 2009-06-30 2011-04-13 严洁 2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢芳辛并[b]吡啶及其组合物
CA2793836C (en) 2009-10-21 2020-03-24 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
CA2793835C (en) 2009-10-21 2021-07-20 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
US20130143897A1 (en) 2010-08-10 2013-06-06 Lupin Limited Oral controlled release pharmaceutical compositions of blonanserin
CN102372673B (zh) * 2010-08-27 2014-04-09 天津市医药集团技术发展有限公司 布南色林结晶及其制备方法
CN102093289B (zh) * 2010-10-29 2012-12-19 常州华生制药有限公司 布南色林中间体的制备方法
CN102030707A (zh) * 2010-11-12 2011-04-27 深圳万和制药有限公司 布南色林中间体的制备方法
HUE065700T2 (hu) 2011-05-03 2024-06-28 Agios Pharmaceuticals Inc Piruvát-kináz aktivátorok terápiában történõ alkalmazásra
CN102827170A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN104114543B (zh) 2012-01-06 2019-03-15 安吉奥斯医药品有限公司 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
MX365747B (es) 2012-10-15 2019-06-12 Agios Pharmaceuticals Inc Compuestos derivados de diarilurea de sulfonamida de arilo y sus usos.
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
EP3019480B1 (en) 2013-07-11 2020-05-06 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
WO2015138839A1 (en) 2014-03-14 2015-09-17 Agios Pharmaceuticals, Inc. Pharmaceutical compositions of therapeutically active compounds
CN104311487B (zh) * 2014-09-22 2016-08-24 江苏正大丰海制药有限公司 一种布南色林晶型及其制备方法
LT3307271T (lt) 2015-06-11 2023-10-25 Agios Pharmaceuticals, Inc. Piruvatkinazės aktyvatorių panaudojimo būdai
DK3362065T3 (da) 2015-10-15 2024-06-17 Servier Lab Kombinationsbehandling omfattende ivosidenib, cytarabin og daunorubicin eller idarubicin til behandling af akut myeloid leukæmi
MX2018004586A (es) 2015-10-15 2018-08-16 Agios Pharmaceuticals Inc Terapia de combinacion para tratar tumores malignos.
KR20190028109A (ko) 2017-09-08 2019-03-18 연성정밀화학(주) 블로난세린 함유 서방성 제제
CN110575438A (zh) * 2018-06-07 2019-12-17 湖南省湘中制药有限公司 一种布南色林固体分散体的制备及其应用
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
KR20210139317A (ko) 2019-03-13 2021-11-22 오츠카 세이야쿠 가부시키가이샤 2급 아민을 함유하는 화합물의 아민 부분에 중수소 저급 알킬을 도입하는 방법
CN113698346A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质b的制备方法
CN113698347A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质f的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128588A (en) * 1978-03-29 1979-10-05 Dainippon Pharmaceut Co Ltd Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
FR2602771B1 (fr) * 1986-08-12 1988-11-04 Rhone Poulenc Sante Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ATE107922T1 (de) 1994-07-15
EP0385237A2 (en) 1990-09-05
DK0385237T3 (da) 1994-07-25
NO177095C (no) 1995-07-19
HU204810B (en) 1992-02-28
EP0385237B1 (en) 1994-06-29
HU901275D0 (en) 1990-05-28
FI94413B (fi) 1995-05-31
ES2058630T3 (es) 1994-11-01
FI94413C (fi) 1995-09-11
AU5060490A (en) 1990-09-06
NO900991L (no) 1990-09-04
US5021421A (en) 1991-06-04
RU2075478C1 (ru) 1997-03-20
DE69010232D1 (de) 1994-08-04
EP0385237A3 (en) 1991-03-20
FI901030A0 (fi) 1990-03-01
CA2011346A1 (en) 1990-09-03
HUT53361A (en) 1990-10-28
NO177095B (no) 1995-04-10
CA2011346C (en) 1999-08-03
DD292909A5 (de) 1991-08-14
KR900014358A (ko) 1990-10-23
DE69010232T2 (de) 1994-12-01
NO900991D0 (no) 1990-03-01
AU623981B2 (en) 1992-05-28
KR0149649B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
HK1005872A1 (en) 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same
CS556587A2 (en) Process for preparing aminoderivatives
HU903090D0 (en) Process for the preparation of n-(aryl-oxy-alkyl)-heteroaryl-piperidines and heteroaryl-piperazines and pharmaceutical compositions containing them
MY129970A (en) Hypolipidaemic compounds
CA2203274A1 (en) Apolipoprotein-b synthesis inhibitors
HUT50160A (en) Process for production of derivatives of tiophene and medical compositions containing them as active substance
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
CS185091A3 (en) Novel n-benzyl-n'-phenyl and phenylalkyl-thioureas
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
PT96123A (pt) Metodo de preparacao de um medicamento para tratamento da infeccao do pneumocystis carinii
NO903084D0 (no) Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100219